Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla® (AG200-15)

June 24, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search